Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NYSE:PINS
NYSE:PINSInteractive Media and Services

A Look At Pinterest (PINS) Valuation After Elliott Investment And Major Share Repurchase Program

The recent $1b investment from Elliot Investment Management and Pinterest (PINS) board approval of a combined $4.5b share repurchase program have put the visual discovery platform back in focus for investors. See our latest analysis for Pinterest. The share price story has been choppy, with a 14.19% 7 day share price return and 7.19% 30 day share price return contrasting with a 24.25% year to date share price decline and a 20.35% 1 year total shareholder return decline. Recent momentum is...
TSE:7269
TSE:7269Auto

Suzuki Motor (TSE:7269) Valuation Check After Glydways Autonomous Mobility Partnership

Suzuki Motor (TSE:7269) drew fresh attention after co-leading Glydways’ $170m Series C funding, pairing its manufacturing role with the autonomous vehicle startup’s planned pilots in the UAE, greater New York City, and Atlanta from 2026. See our latest analysis for Suzuki Motor. Despite the Glydways partnership catching headlines, Suzuki Motor’s share price return has been weak in recent months. The 90 day share price return is 19.7% and the year to date share price return is 20.8%, while the...
NasdaqGS:NTAP
NasdaqGS:NTAPTech

A Look At NetApp (NTAP) Valuation After New Google Cloud Sovereign AI Agreement

NetApp (NTAP) has drawn fresh investor attention after signing a four year Enterprise Agreement with Google Cloud to deploy its storage platform in Google Distributed Cloud’s air gapped, sovereign environments for highly regulated workloads. See our latest analysis for NetApp. That news comes on top of a busy period for NetApp, including its recent collaboration with Nutanix and moves to strengthen cyber resilience. The stock’s short term share price momentum contrasts with a much stronger...
NYSE:EOG
NYSE:EOGOil and Gas

A Look At EOG Resources (EOG) Valuation After Heartland Advisors Highlights Cash Returns And Efficiency

Heartland Advisors recently cited EOG Resources (EOG) as a top contributor in its Q1 2026 Mid Cap Value Fund letter, highlighting the producer’s focus on costs and cash returns through dividends and share repurchases. See our latest analysis for EOG Resources. EOG Resources’ share price has eased in the short term, with a 7 day share price return of 5.7% and 30 day share price return of 6.6%. However, the 90 day share price return of 21.9%, alongside a 1 year total shareholder return of 20.4%...
NasdaqGS:TRMB
NasdaqGS:TRMBSoftware

Trimble (TRMB) Is Up 7.0% After Bullish Q1 2026 Earnings Hopes - Has The Bull Case Changed?

Trimble Inc. recently entered the spotlight ahead of its fiscal first-quarter 2026 earnings release, with analysts expecting a double-digit year-over-year earnings increase and noting that the company has exceeded consensus estimates in each of the last four quarters. This consistent outperformance has led to a highly bullish analyst consensus, with many viewing Trimble as a potential earnings outlier in the industrial technology space. Next, we’ll examine how expectations for another strong...
NYSE:BW
NYSE:BWElectrical

Why Babcock & Wilcox (BW) Is Up 5.3% After Class Action Over AI Power Contracts And Ties

In April 2026, Pomerantz LLP announced a class action lawsuit against Babcock & Wilcox Enterprises and certain officers, alleging materially false and misleading statements about a very large AI-related power generation contract, undisclosed ties with its largest shareholder BRC, and misrepresented business prospects under federal securities laws. The complaint centers on whether undisclosed conflicts of interest and questions over the true economics and enforceability of the Applied Digital...
NYSE:NUVB
NYSE:NUVBPharmaceuticals

A Look At Nuvation Bio’s Valuation As Ibtrozi Uptake And Q1 Earnings Expectations Gain Attention

Renewed attention on Nuvation Bio (NUVB) is building ahead of its upcoming Q1 earnings, as recent analyst commentary focuses on Ibtrozi’s early commercial uptake and the company’s efforts to widen the drug’s reach globally. See our latest analysis for Nuvation Bio. Nuvation Bio’s share price has recently picked up, with a 1 day share price return of 5.61% and 30 day share price return of 18.69%. However, year to date the share price return is a 40.79% decline, while the 1 year total...
NYSE:NVST
NYSE:NVSTMedical Equipment

Are Kerr Dental’s Efficiency Gains Hinting at a New Competitive Edge for Envista (NVST)?

Kerr Dental, a key Envista Holdings subsidiary, recently launched ZenSeal Pro with ZenSave Tips and the Demi Pro cordless curing light, introducing new bioceramic sealer delivery and curing technologies aimed at reducing material waste and improving clinical access. By focusing on efficiency gains, such as cutting bioceramic sealer waste by around one‑third, these products highlight Envista’s emphasis on value and workflow improvements for dental practices. Next, we’ll examine how Kerr’s...
NYSE:MET
NYSE:METInsurance

Assessing MetLife (MET) Valuation After Recent Share Price Momentum

MetLife stock overview following recent performance MetLife (MET) shares have moved higher over the past month, with a return of about 14%, while the past 3 months show a smaller gain. This recent performance has drawn fresh attention to the insurer’s fundamentals. See our latest analysis for MetLife. At a share price of US$78.08, MetLife’s recent 1 month share price return of 13.82% and 7 day return of 5.68% suggest building momentum, while the 1 year total shareholder return of 10.82% sits...
NasdaqGM:NRIX
NasdaqGM:NRIXBiotechs

Nurix Therapeutics (NRIX) Is Up 9.2% After Reporting Sharply Lower Q1 Revenue And Wider Loss

Nurix Therapeutics reported past first-quarter 2026 earnings, with revenue of US$6.25 million versus US$18.45 million a year earlier and a net loss of US$87.17 million versus US$56.35 million. The wider basic loss per share from continuing operations, US$0.79 compared with US$0.67, highlights how the company’s cost and revenue profile has shifted year over year. With these results showing sharply lower revenue, we’ll now examine how this development shapes Nurix Therapeutics’ investment...
SEHK:1672
SEHK:1672Biotechs

Assessing Ascletis Pharma (SEHK:1672) Valuation After ASC30_39 Obesity Candidate Advances Toward FDA IND Filing

Ascletis Pharma (SEHK:1672) announced the selection of its ASC30_39 fixed dose combination obesity therapy candidate for clinical development. The company plans to file an IND with the U.S. FDA in the third quarter of 2026. See our latest analysis for Ascletis Pharma. That obesity announcement comes after a strong run in the shares, with the latest price at HK$18.48, a 30 day share price return of 25.03% and a 1 year total shareholder return of 274.09%. This suggests momentum has been...
NYSE:PBT
NYSE:PBTOil and Gas

A Look At Permian Basin Royalty Trust (PBT) Valuation After Oil Shock And Governance Uncertainty

Oil shock and governance overhang put Permian Basin Royalty Trust in focus Geopolitical tensions in the Strait of Hormuz have pushed crude prices higher in 2026. This has put Permian Basin Royalty Trust (PBT) and its oil linked royalty payouts under closer scrutiny for income focused investors. See our latest analysis for Permian Basin Royalty Trust. At a share price of US$21.41, Permian Basin Royalty Trust has paired a 21.72% year to date share price return with a 5 year total shareholder...
TSE:6857
TSE:6857Semiconductor

Does Advantest (TSE:6857) Silicon Valley Test Hub Reinforce Its Edge In AI-era Semiconductors?

Advantest Corporation has opened its first Advantest Innovation Center in San Jose and is building a second in Sunnyvale, creating labs and cleanroom facilities for partners to co-develop advanced test solutions for next-generation semiconductor technologies; the San Jose site is already operating and initial manufacturer and supplier collaborations are underway. By offering early-stage, on-site collaboration on advanced packaging, complex device architectures, and test insertions, these...
TSX:EIF
TSX:EIFAirlines

Is It Too Late To Consider Exchange Income (TSX:EIF) After 124% One Year Surge?

Investors may be wondering if Exchange Income at around $105.54 still represents good value after a strong run, or if most of the potential upside has already been reflected in the price. The stock has logged returns of 0.3% over the past week, 2.5% over the past month, 29.0% year to date and 124.1% over the last year, with 3 year and 5 year returns of 125.5% and 247.8% respectively. Recent coverage has focused on Exchange Income's position in the transportation space, as investors reassess...
NasdaqGS:PGNY
NasdaqGS:PGNYHealthcare

A Look At Progyny (PGNY) Valuation After The Launch Of Progyny Select For Small Employers

Progyny (PGNY) has launched Progyny Select, a fully insured supplemental fertility and women’s health plan targeting small U.S. employers with fixed premium pricing, drawing investor attention to a new potential demand pool. See our latest analysis for Progyny. The 11.17% 7 day share price return suggests traders are reacting positively to Progyny Select. However, the 90 day share price return of 26.10% and 3 year total shareholder return of 47.69% indicate longer term momentum has been...